Anaplastic large cell lymphoma · 5 regimens
Cost vs Efficacy · 2 points
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
BV-CHP Variant #01 | — | R 85 921 | 21d | ~48.2 mo | — | ~70 | ~R 6 014 481 PFS proxy · indirect | 2 |
CHOEP-14 Variant #01 | — | R 1 887 | 14d | — | — | — | — | — |
CHOEP-21 Variant #01 | — | R 1 887 | 21d | — | — | — | — | — |
DA-EPOCH Variant #01 | — | R 1 522 | 21d | — | — | — | — | — |
CHOP Variant #13 | — | R 859 | 21d | ~15.5 mo | — | ~23 | ~R 19 749 PFS proxy · indirect | 3 |
5 of 5 regimens shown